Lilly, Novo to Lower Obesity Drug Prices in Trump Deal
Eli Lilly and Novo Nordisk, two major pharmaceutical companies, have reached an agreement with the Trump administration to lower the prices of their obesity drugs, Zepbound and…
Every developing story NewsAI is tracking for obesity — as timelines, not a pile of articles.
Eli Lilly and Novo Nordisk, two major pharmaceutical companies, have reached an agreement with the Trump administration to lower the prices of their obesity drugs, Zepbound and…
The article discusses President Donald Trump's plans to launch a new investigation into foreign drug prices. According to the report, the investigation will focus on ensuring that…
The Democratic National Committee (DNC) has launched a new tactic to highlight President Trump's proposed cuts to Medicaid. They have erected billboards near four struggling rural…
The most recent articles mentioning obesity, grouped by month. Open a story above to read it as a full timeline.
President Trump announced a deal with pharmaceutical companies Eli Lilly and Novo Nordisk to lower the prices of obesity drugs for Medicare, Medicaid, and self-paying patients.…
The article discusses a new drug pricing deal announced by President Trump, which aims to address the issue of high drug prices in the United States. The deal involves a range of…
The Trump administration is planning a pilot program to cover weight loss drugs under Medicaid and Medicare, the government health insurance systems for low-income individuals and…